Resultados de búsqueda - "immunotherapy"

  • Mostrando 1 - 16 Resultados de 16
Limitar resultados
  1. 1

    Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines por Larenas Linnemann, Désirée, Rodríguez Pérez, Noel, Luna Pech, Jorge A., Rodríguez González, Mónica, Blandón Vijil, María Virginia, Del Río Navarro, Blanca E., Costa Domínguez, María del Carmen, Navarrete Rodríguez, Elsy Maureen, Macouzet Sánchez, Carlos, Ortega Martell, José Antonio, Pozo Beltrán, César Fireth, Estrada Cardona, Alan, Arias Cruz, Alfredo, Rodríguez Galván, Karen Guadalupe, Brito Díaz, Herson, Canseco Raymundo, María Del Rosario, Castelán Chávez, Enrique Emanuel, Escalante Domínguez, Alberto José, Gálvez Romero, José Luis, Gómez Vera, Javier, González Díaz, Sandra Nora, Guerrero Núñez, María Gracia Belinda, Hernández Colín, Dante Daniel, Macías Weinmann, Alejandra, Mendoza Hernández, David Alejandro, Meneses Sánchez, Néstor Alejandro, Mogica Martínez, María Dolores, Moncayo Coello, Carol Vivian, Montiel Herrera, Juan Manuel, O'Farril Romanillos, Patricia María, Onuma Takane, Ernesto, Ortega Cisneros, Margarita, Rangel Garza, Lorena, Stone Aguilar, Héctor, Torres Lozano, Carlos, Venegas Montoya, Edna, Wakida Kusunoki, Guillermo, Partida Gaytán, Armando, López García, Aída Inés, Macías Robles, Ana Paola, Ambriz Moreno, María de Jesús, Azamar Jácome, Amyra Ali, Beltrán de Paz, Claudia Yusdivia, Caballero López, Chrystopherson, Fernández de Córdova Aguirre, Juan Carlos, Fernández Soto, José Roberto, Lozano Sáenz, José Santos, Oyoqui Flores, José Joel, Osorio Escamilla, Roberto Efrain, Ramírez Jiménez, Fernando, Rivero Yeverino, Daniela, Martínez Infante, Eric, Medina Ávalos, Miguel Alejandro

    Publicado 2020
    “…Background: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. …”
    Enlace del recurso
    Artículo
  2. 2

    100 years of immunotherapy: the Monaco charter por Canonica, Giorgio Walter, Baena Cagnani, Carlos E., Compalati, Enrico, Bohle, Barbara, Bonini, Sergio, Bousquet, Jean J., Cox, Linda, Fink Wagner, Antje H., González Díaz, Sandra Nora, Jacobsen, Lars, Passalacqua, Giovanni, Pawankar, Ruby, Vieths, Stefan, Yusuf, Osman M., Zuberbier, Torsten

    Publicado 2012
    “…Aims of the Monaco Charter: (1) to present the current evidence on the efficacy and safety of allergen-specific immunotherapy (SIT) and to address the reasons for its underuse in clinical practice; (2) to develop strategies to increase the awareness about the benefits and the hazards of SIT in allergic patients, lay public and healthcare professionals not trained in allergy, and (3) to make SIT accessible and affordable to eligible patients.…”
    Enlace del recurso
    Artículo
  3. 3
  4. 4
  5. 5

    Low dose of sublingual immunotherapy in patients with allergic rhinitis in a randomized double-blind placebocontrolled study por Leal Villarreal, Lucía, Huerta López, José G., Salinas Carmona, Mario César, Cárdenas Estrada, Eloy, Muñoz Espinosa, Linda Elsa, Castro Corona, María de los Ángeles, Medina de la Garza, Carlos Eduardo

    Publicado 2010
    “…Background: Few placebo controlled studies for sublingual immunotherapy (SLIT) have been performed so far in Latin America, and some issues like treatment scheme and doses remain uncertain Objective: to asses improvement in nasal, pharyngeal and ocular symptoms with low doses of SLIT to Dermatophagoides pteronyssinus comparing it with a placebo, in a Mexican population with allergic rhinitis (AR). …”
    Enlace del recurso
    Artículo
  6. 6

    Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma treated with cabozantinib and nivolumab por Salazar Mejía, Carlos Eduardo, Oyervides Juárez, Víctor Manuel, Wimer Castillo, Blanca Otilia, Vidal Gutiérrez, Oscar, Garza Guajardo, Raquel, Grande, Enrique

    Publicado 2020
    “…This is the first documented case of renal CT with a CDC component that obtained a partial response to combined treatment with immunotherapy and target therapy as first-line treatment; obtaining the longest overall survival reported in the setting of a metastatic renal CT with this histological combination. …”
    Enlace del recurso
    Artículo
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Estudio del mecanismo de muerte celular inducido por el IMMUNEPOTENT CRP en combinación con ciclofosfamida en células de cáncer de mama por Rivera Lazarín, Ana Luisa

    Publicado 2020
    “…Current main proposes suggest the integration of immunotherapies in combined therapies in order to reduce the doses required for tumor eradication, to reduce adverse effects and to avoid treatment-resistance. …”
    Enlace del recurso
    Tesis
  14. 14

    Estudio del mecanismo de muerte celular inducido por el IMMUNEPOTENT CRP en combinación con ciclofosfamida en células de cáncer de mama por Rivera Lazarín, Ana Luisa

    Publicado 2020
    “…Current main proposes suggest the integration of immunotherapies in combined therapies in order to reduce the doses required for tumor eradication, to reduce adverse effects and to avoid treatment-resistance. …”
    Enlace del recurso
    Tesis
  15. 15

    Evaluación de la administración vía aerosol de la vacuna sintética basada en WT1-CPG en un modelo de cáncer pulmonar. por Arriaga Hernández, Daniela

    Publicado 2016
    “…Its restricted expression in normal tissue makes it an attractive target for cancer immunotherapy. The aim of this study is to determine whether an aerosolized peptide vaccine with WT1- specific T CD8+ and T CD4+ epitopes in combination with CpG is able to induce an effective antitumor response against a lung cancer B16F10 model. …”
    Enlace del recurso
    Tesis
  16. 16

    Evaluación de la administración vía aerosol de la vacuna sintética basada en WT1-CPG en un modelo de cáncer pulmonar. por Arriaga Hernández, Daniela

    Publicado 2016
    “…Its restricted expression in normal tissue makes it an attractive target for cancer immunotherapy. The aim of this study is to determine whether an aerosolized peptide vaccine with WT1- specific T CD8+ and T CD4+ epitopes in combination with CpG is able to induce an effective antitumor response against a lung cancer B16F10 model. …”
    Enlace del recurso
    Tesis

Herramientas de búsqueda: